Immunofluorescence analysis of A-431 (epidermoid carcinoma), U-251MG (glioma), and U-2 OS (osteosarcoma) cell lines, as reported in the THPA, was used to investigate the subcellular distribution of CCDC138 (Figure 4A). This evidence concerns the gene CCDC138 and central nervous system cancer.